GAM
Groupama Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.4M | Sell |
67,870
-22,742
| -25% | -$11.8M | 0.59% | 41 |
|
|
2025
Q1 | $57.8M | Buy |
90,612
+10,273
| +13% | +$6.55M | 1.15% | 24 |
|
|
2024
Q4 | $56.4M | Buy |
80,339
+9,062
| +13% | +$6.37M | 1.15% | 24 |
|
|
2024
Q3 | $60.2M | Buy |
71,277
+4,648
| +7% | +$3.92M | 1.56% | 17 |
|
|
2024
Q2 | $70M | Buy |
66,629
+16,417
| +33% | +$17.3M | 0.95% | 24 |
|
|
2024
Q1 | $64.5M | Sell |
50,212
-17,159
| -25% | -$22M | 1.18% | 21 |
|
|
2023
Q4 | $59.2M | Buy |
+67,371
| New | +$59.2M | 1.54% | 14 |
|